98%
921
2 minutes
20
Objectives: Carbapenem-resistant Acinetobacter baumannii (A. baumannii; CRAB) isolates represent a serious public health concern. Recently, a novel molecule, the cefiderocol (FDC), has emerged as a promising therapeutic option for CRAB infections. In the present study, we analysed the genomes of five A. baumannii ST2 isolates from four hospitalized patients. All patients were treated with FDC and an ampicillin/sulbactam (AMP/SUL) combination.
Methods: Whole-genome sequencing of the five CRAB isolates was performed using an Illumina MiSeq instrument. A detailed bioinformatic analysis was carried out to acquire information about genotyping, antimicrobial resistance genes (ARGs), virulence associated genes (VAGs), single nucleotide polymorphisms (SNPs), and the phylogenetic tree of the five CRAB isolates.
Results: Among the five CRAB isolates, only three (Ab.2, Ab.3, and Ab.4) exhibited resistance to FDC. The genomes of all isolates were highly similar, and multilocus sequence typing (MLST) analysis indicated they all belong to sequence type 2 (ST2), corresponding to international clone 2. Phylogenetic analysis suggests that isolates Ab.2, Ab.3, and Ab.4 may share a common ancestor or be linked by a possible transmission event. In contrast, isolates Ab.1 and Ab.5 were more divergent from the other three. Nevertheless, all five isolates harboured the same ARGs and VAGs. The OXA-23, OXA-66, and ADC-25 β-lactamases were detected in all strains. The FDC-non-susceptible isolates showed a K235N/H370Y double mutation within PBP3, along with a G370C substitution in PBP1a.
Conclusions: The four clinical cases described in this study represent an important example of the efficacy and good practice of FDC plus AMP/SUL combination in the treatment of critical patients suffering from CRAB infections. © 2025 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jgar.2025.06.014 | DOI Listing |
Virology
September 2025
Department of Microbiology, Faculty of Pharmacy, Ahram Canadian University (ACU), 6th October City, Giza, 12566, Egypt. Electronic address:
Background: Carbapenem-resistant Acinetobacter baumannii (CRAB) has recently become a serious cause for global concern because of non-susceptibility to multiple antimicrobial classes, its prevalence in nosocomial infections, and the lack of effective treatments against such a pathogen.
Methods: This study isolated two lytic phages from hospital sewage, purified, propagated, characterized morphologically by transmission electron microscopy, and genomically by Oxford Nanopore Sequencing. The phage lysates were then formulated individually as carboxymethylcellulose (CMC) 5 % w/v hydrogels.
J Antimicrob Chemother
August 2025
Department of Microbiology, School of Basic Medicine, First Clinical Medical College, Faculty of Medicine, Yangzhou University, Yangzhou 225001, China.
Background: Carbapenem-resistant Acinetobacter baumannii (CRAB) causes multiple anatomical site infections, representing a significant public health threat.
Aim: This study reports the isolation and characterization of a carbapenem-resistant A. baumannii harbouring blaOXA-542, followed by a comprehensive investigation of its antimicrobial resistance mechanisms and genomic characteristics.
Biomacromolecules
September 2025
Jiangsu Co-Innovation Center of Efficient Processing and Utilization of Forest Resources, International Innovation Center for Forest Chemicals and Materials, College of Chemical Engineering, Nanjing Forestry University, Longpan Road 159, Nanjing 210037, China.
Chitin/protein nanofibrils are extracted from decalcified crab shells using 100 mM hydrochloric acid and ultrasonication or high-pressure homogenization, achieving a 94% recovery rate. Further increases in the temperature or duration enhance hydrolysis, leading to a significant reduction in the nanofibril size. The increase in the number of acidic amino acids within the nanofibrils enhances electrostatic repulsion, promoting their dispersion under acidic conditions.
View Article and Find Full Text PDFVirulence
December 2025
National Institute for Antibiotic Resistance and Infection Control, Ministry of Health, Tel Aviv, Israel.
Carbapenem-resistant (CRAB) is an important threat to hospitalized patients. The virulence of varies between strains and geographic locations, which is believed to be related to its genetic plasticity. A comprehensive evaluation of virulence factor (VF) content of CRAB across genetically related clones is lacking.
View Article and Find Full Text PDFIndian J Pharmacol
September 2025
Department of Microbiology, JSS Medical College, Mysuru, Karnataka, India.
Objective: The purpose of this study was to determine the in vitro synergistic effect of meropenem and sulbactam drug combinations through checkerboard assay against Carbapenem-resistant Acinetobacter baumannii (CRAB) to establish potential treatment options.
Materials And Methods: CRAB was cultured from the clinical samples of Endotracheal aspirate, blood, pus, throat swab, and urine specimens from 80 patients with suspected nosocomial infection in 1 year. Minimum inhibitory concentration (MIC) was determined for meropenem and sulbactam drugs individually.